Pacific Biosciences of California, which is developing a system that performs real-time DNA sequencing, will see its quiet period end on Sunday, December 5. On October 26, the company raised $200 million by offering 12.5 million shares at $16, within the range...read more
Pacific Biosciences of California, which is developing a system that performs real-time DNA sequencing, raised $200 million by offering 12,500,000 shares at $16, the midpoint of the $15-$17 range. The news comes the same day that another next-generation DNA...read more
Pacific Biosciences of California, which is developing a system that performs DNA sequencing using single molecule real-time technology, announced terms for its IPO on Tuesday. The Menlo Park, CA-based company plans to raise $200 million by offering 12.5...read more
Pacific Biosciences of California, which is developing a system that performs DNA sequencing using its proprietary single molecule real-time (SMRT) technology, filed on Monday with the SEC to raise up to $200 million in an initial public offering. The Menlo...read more
Pacific Biosciences quiet period ends December 5
Pacific Biosciences of California, which is developing a system that performs real-time DNA sequencing, will see its quiet period end on Sunday, December 5. On October 26, the company raised $200 million by offering 12.5 million shares at $16, within the range...read more
Pacific Biosciences prices IPO at $16, the midpoint of the range
Pacific Biosciences of California, which is developing a system that performs real-time DNA sequencing, raised $200 million by offering 12,500,000 shares at $16, the midpoint of the $15-$17 range. The news comes the same day that another next-generation DNA...read more
Pacific Biosciences of California sets terms for $200 million IPO
Pacific Biosciences of California, which is developing a system that performs DNA sequencing using single molecule real-time technology, announced terms for its IPO on Tuesday. The Menlo Park, CA-based company plans to raise $200 million by offering 12.5...read more
Pacific Biosciences of California files for $200 million IPO
Pacific Biosciences of California, which is developing a system that performs DNA sequencing using its proprietary single molecule real-time (SMRT) technology, filed on Monday with the SEC to raise up to $200 million in an initial public offering. The Menlo...read more